Canada delivers landmark ruling in favour of big pharma

22-02-2022

Canada delivers landmark ruling in favour of big pharma

Kristi Blokhin / Shutterstock.com

The Quebec Court of Appeal in Canada has ruled that the 2019 amendments to the Patented Medicines Regulations, governing the country’s Patented Medicine Prices Review Board (PMPRB) are partially invalid.


big pharma, Canada, Fasken, federal government, Patented Medicine Prices Review Board, Patented Medicines Regulation

LSIPR